Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
about
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsHistory of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophreniaPharmacology and biochemistry of haloperidolIncreased concentrations of 3-methoxy-4-hydroxyphenylethyl-eneglycol and homovanillic acid in rat brain after treatment with BE-2254 ("HEAT")Dyskinesias elicited by methamphetamine: susceptibility of former methadone-consuming monkeysAnticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neurolepticsMetoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesiasTime-dependent effects of phenothiazines on dopamine turnover in psychiatric patientsPharmacology of M & B 18,706, a drug which selectively reduces decerebrate rigidityClinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome.Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients.Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders.There and back again: a tale of norepinephrine and drug addiction.Pharmacokinetics of pimozide in adults and children with Tourette's syndrome.Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina.Abnormal negative feedback processing in first episode schizophrenia: evidence from an oculomotor rule switching taskHypothermic action of bromocriptineBehavioural changes induced in conscious mice by intracerebroventricular injection of catecholamines, acetylcholine and 5-hydroxytryptamine.Influence of dopamine and noradrenaline on isolated cerebral arteries of the dog.Heterogeneity of inhibitory mechanisms in the nucleus accumbens and preoptic area of the [proceedings]Cardiovascular effects of dopamine after central administration into conscious catsEffects of spiperone on self-stimulation and other activities of the Mongolian gerbil.Modulation of noradrenergic transmission in the rabbit ear artery by dopamineTreatments for chronic psychosis.Interaction of (+)-amphetamine with cerebral dopaminergic neurones in two strains of mice, that show different temperature responses to this drug.The effect of chronic haloperidol treatment on some cardiovascular parameters in cats.Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.An effect of haloperidol on the increased food and water intake induced in rabbits by 2-deoxy-D-glucosePsychoactive drugs and human sexual behavior: the role of serotonergic activity.Targeting the dopamine D2 receptor in schizophrenia.From prediction error to psychosis: ketamine as a pharmacological model of delusions.L-dopa and arousal.Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia.Disrupted prediction-error signal in psychosis: evidence for an associative account of delusionsChlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs.Self-inhibition by dopaminergic neurons.New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.Enhancement of alcohol withdrawal convulsions in mice by haloperidol.Altered hypothermic responsivness to (+)-amphetamine.Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.
P2860
Q28258681-2A4A2B35-BA74-4FCC-B465-6B5B111BAC7EQ28283494-8D707DAF-AF77-4015-9F80-84F2C99B7F73Q28316539-68EAB790-5FEF-4FFF-B8F4-6F15562075AEQ28323533-33F2DAA3-8BB7-4DDF-8627-7826273936D2Q28329752-24986EB6-8C4E-4231-BE62-CFAD5361C365Q28335688-7D54F025-1200-4FBE-9CF3-FE10DA310D32Q28336736-F4B606C9-84CE-4F68-A7D8-8ACC66EFF4E5Q28339708-A0A08B2F-250F-4B36-9C00-D08E9FAF145BQ28362801-27DC7AB8-2BE5-45A8-B033-24FC82B8122FQ33622433-8EE6D4BB-6FFF-47FB-BAF1-9F8E6B526426Q34110491-2ACDA791-D90F-4E62-BEA5-27B87BA2CC81Q34174978-4152A7E1-BC09-475C-9F83-36E4388A6A32Q34590409-258E639A-3184-4D58-AC44-C8AA246DD55DQ34688800-EFC76C4E-20C8-48DC-B6F2-19F6094BED56Q34691865-BC273AA6-885F-41F7-A59C-86761F21D73DQ35159829-26CED448-37E6-4A05-80A6-2774CAFAD140Q35174959-0484174C-2A9F-437F-8117-FE579E5AB0FCQ35175439-33C172FE-F7E6-4478-94EF-9FF109BAFE4CQ35176154-2EA04C47-F82F-4FA9-AFD6-6B69D66A508EQ35176460-0A230A57-081F-4E2F-8669-22F8F769C426Q35176608-5D72D17F-5C09-4713-A855-90477FE2FA95Q35177676-37DD446F-5004-4C55-AA48-98A485096CB9Q35177857-20DDB654-D98E-4F68-B366-A486C1A6188BQ35236418-3A836935-5400-4769-9C08-F49F7485EEBBQ35600677-8596426F-E02A-40DD-BB1E-924E6AD37704Q35886707-7A644649-6D2C-4251-BE74-8E72BB4820C3Q35939972-68814D70-F53F-4A60-8018-35D56F204123Q36096104-5901339F-891F-4B13-8636-560C8D393F72Q36272836-FC9E3C04-8265-4508-9A1A-35BFEF11DAAEQ36539461-AE25FEA3-8AA7-4E74-A8FE-C3186B316868Q36860032-B5F7670A-1E7C-4D69-9785-11C0A017493BQ37098326-FD996C32-E170-47AA-B473-1C4088993EE1Q37306496-482D8161-BF3D-471E-99EC-184232F45499Q37338753-F4B136CB-967F-4802-89FE-E153361308B7Q37487847-16B348B4-6A20-4DFA-A478-BB6AC1096229Q38160998-C71F9190-F9F9-4DB4-8B6E-8FA7DA50E044Q38233857-83122126-1BBE-4108-A0A2-392F424EFC7DQ38548322-CC7B9318-2752-42BC-A2E4-DF3ACE20D7DBQ39098965-512E9E1A-1AC4-4396-85B3-654A3EE6E516Q39099256-F1A74492-CF70-4137-A566-936875E80C93
P2860
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@en
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@nl
type
label
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@en
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@nl
prefLabel
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@en
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@nl
P2093
P1476
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
@en
P2093
Butcher SG
Ungerstedt U
P304
P356
10.1016/0014-2999(70)90006-3
P407
P50
P577
1970-01-01T00:00:00Z